These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24700532)

  • 1. Cell/tissue processing information system for regenerative medicine.
    Iwayama D; Yamato M; Tsubokura T; Takahashi M; Okano T
    J Tissue Eng Regen Med; 2016 Nov; 10(11):908-915. PubMed ID: 24700532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of the regulation and development of cell therapy products in Japan].
    Igarashi Y; Sato Y
    Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Industrialization of regenerative medicine in Japan].
    Sugawara K; Hata K
    Clin Calcium; 2008 Dec; 18(12):1751-6. PubMed ID: 19043189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan.
    Okada K; Koike K; Sawa Y
    Regen Ther; 2015 Jun; 1():80-83. PubMed ID: 31245444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [J-TEC's efforts to industrialize regenerative medicine in Japan].
    Inoie M
    Nihon Yakurigaku Zasshi; 2024; 159(3):138-143. PubMed ID: 38692875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory perspectives of Japan.
    Kusakabe T
    Biologicals; 2015 Sep; 43(5):422-4. PubMed ID: 26028474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products.
    Hourd P; Chandra A; Alvey D; Ginty P; McCall M; Ratcliffe E; Rayment E; Williams DJ
    Regen Med; 2014; 9(6):799-815. PubMed ID: 25431916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs.
    Abou-El-Enein M; Römhild A; Kaiser D; Beier C; Bauer G; Volk HD; Reinke P
    Cytotherapy; 2013 Mar; 15(3):362-83. PubMed ID: 23579061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Translational/regulatory science researches of NIHS for regenerative medicine and cellular therapy products].
    Sato Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):6-9. PubMed ID: 25707195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
    Maekawa T
    Rinsho Byori; 2004 May; 52(5):430-4. PubMed ID: 15206130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacturing road map for tissue engineering and regenerative medicine technologies.
    Hunsberger J; Harrysson O; Shirwaiker R; Starly B; Wysk R; Cohen P; Allickson J; Yoo J; Atala A
    Stem Cells Transl Med; 2015 Feb; 4(2):130-5. PubMed ID: 25575525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualification of computerized monitoring systems in a cell therapy facility compliant with the good manufacturing practices.
    Del Mazo-Barbara A; Mirabel C; Nieto V; Reyes B; García-López J; Oliver-Vila I; Vives J
    Regen Med; 2016 Sep; 11(6):521-8. PubMed ID: 27513321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical GMP: past, present, and future--a review.
    Patel KT; Chotai NP
    Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the electronic patient record system based on problem oriented system.
    Uto Y; Iwaanakuchi T; Muranaga F; Kumamoto I
    Stud Health Technol Inform; 2013; 192():1036. PubMed ID: 23920810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory science research to facilitate the development of cell/tissue-processed products].
    Sato Y; Tsutsumi H; Sawada R; Suzuki T; Yasuda S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):16-9. PubMed ID: 24340665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in Japan.
    Okada K; Sato Y; Sugiyama D; Sawa Y
    Clin Ther; 2018 Jul; 40(7):1076-1083. PubMed ID: 29958729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act.
    Mizutani M; Samejima H; Terunuma H; Kino-Oka M
    Regen Ther; 2016 Dec; 5():25-30. PubMed ID: 31245497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-839. PubMed ID: 28756845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell research and regenerative medicine in 2014: first year of regenerative medicine in Japan.
    Okano H
    Stem Cells Dev; 2014 Sep; 23(18):2127-8. PubMed ID: 25192239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.